Статті в журналах з теми "Therapeutic modality for cancer"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Therapeutic modality for cancer".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Agarwal, Shashi K. "Exercise: Preventive and Therapeutic Benefits in Cancer." Journal of Cancer Research Updates 10 (October 25, 2021): 10–17. http://dx.doi.org/10.30683/1929-2279.2021.10.02.
Повний текст джерелаKOMIYA, Yoshiaki, Tadayoshi MATSUDA, Ikuhiro UTIDA, Syohei IWAMOTO, and Toshiaki KURASHIMA. "Investigation of therapeutic modality for cancer of the tongue." Japanese Journal of Oral & Maxillofacial Surgery 35, no. 6 (1989): 1617–27. http://dx.doi.org/10.5794/jjoms.35.1617.
Повний текст джерелаDagnelie, P. C., J. W. O. van den Berg, J. D. Bell, C. S. Foster, T. Rietveld, and G. R. Swart. "Fish oil: a new therapeutic modality in cancer cachexia?" Clinical Nutrition 12 (January 1993): 50. http://dx.doi.org/10.1016/0261-5614(93)90296-g.
Повний текст джерелаItoh, Kyogo, and Akira Yamada. "Personalized peptide vaccines: A new therapeutic modality for cancer." Cancer Science 97, no. 10 (October 2006): 970–76. http://dx.doi.org/10.1111/j.1349-7006.2006.00272.x.
Повний текст джерелаTordiglione, Michele, Maurizio Kalli, Vittorio Vavassori, and Roberto Luraghi. "Combined Modality Treatment for Esophageal Cancer." Tumori Journal 84, no. 2 (March 1998): 252–58. http://dx.doi.org/10.1177/030089169808400226.
Повний текст джерелаVandghanooni, Somayeh, Morteza Eskandani, Jaleh Barar, and Yadollah Omidi. "Aptamedicine: a new treatment modality in personalized cancer therapy." BioImpacts 9, no. 2 (November 30, 2018): 66–69. http://dx.doi.org/10.15171/bi.2019.09.
Повний текст джерелаLee, Y., J. Jung, G. Hwang, H. Park, and Y. Im. "Multimodal therapeutic approach in anaplastic thyroid cancer." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 15533. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.15533.
Повний текст джерелаStorozynsky, Quinn, and Mary M. Hitt. "The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer." International Journal of Molecular Sciences 21, no. 22 (November 23, 2020): 8877. http://dx.doi.org/10.3390/ijms21228877.
Повний текст джерелаChen, Lili, Xiaohong Wang, Fangling Ji, Yongming Bao, Jingyun Wang, Xianwu Wang, Lianying Guo, and Yachen Li. "New bifunctional-pullulan-based micelles with good biocompatibility for efficient co-delivery of cancer-suppressing p53 gene and doxorubicin to cancer cells." RSC Advances 5, no. 115 (2015): 94719–31. http://dx.doi.org/10.1039/c5ra17139c.
Повний текст джерелаLi, Mingjing, Fan Yu, Chao Yao, Peng George Wang, Yonghui Liu, and Wei Zhao. "Synthetic and immunological studies on trimeric MUC1 immunodominant motif antigen-based anti-cancer vaccine candidates." Organic & Biomolecular Chemistry 16, no. 6 (2018): 993–99. http://dx.doi.org/10.1039/c7ob02976d.
Повний текст джерелаZhang, Wei, Yang Zang, Yanli Lu, Jinhui Han, Qingyun Xiong, and Jinping Xiong. "Photothermal Effect and Multi-Modality Imaging of Up-Conversion Nanomaterial Doped with Gold Nanoparticles." International Journal of Molecular Sciences 23, no. 3 (January 26, 2022): 1382. http://dx.doi.org/10.3390/ijms23031382.
Повний текст джерелаTalbot, Jean-Noël. "The clinical impact of [18F]-FDG Pet during the opening year of a Pet centre." Brazilian Archives of Biology and Technology 45, spe (September 2002): 61–67. http://dx.doi.org/10.1590/s1516-89132002000500009.
Повний текст джерелаDing, Yi, Ziyi Song, Qian Liu, Shaohua Wei, Lin Zhou, Jiahong Zhou, and Jian Shen. "An enhanced chemotherapeutic effect facilitated by sonication of MSN." Dalton Transactions 46, no. 35 (2017): 11875–83. http://dx.doi.org/10.1039/c7dt02600e.
Повний текст джерелаDatta, Niloy R., Bharati M. Jain, Zatin Mathi, Sneha Datta, Satyendra Johari, Ashok R. Singh, Pallavi Kalbande, Pournima Kale, Vitaladevuni Shivkumar, and Stephan Bodis. "Hyperthermia: A Potential Game-Changer in the Management of Cancers in Low-Middle-Income Group Countries." Cancers 14, no. 2 (January 9, 2022): 315. http://dx.doi.org/10.3390/cancers14020315.
Повний текст джерелаSingh, Nathan. "Modified T cells as therapeutic agents." Hematology 2021, no. 1 (December 10, 2021): 296–302. http://dx.doi.org/10.1182/hematology.2021000262.
Повний текст джерелаPort, Jeffrey L., Mohamed K. Kamel, and Nasser K. Altorki. "Surgery is the Optimum Local Therapeutic Modality for Second Primary Lung Cancer." Seminars in Thoracic and Cardiovascular Surgery 28, no. 1 (2016): 201–2. http://dx.doi.org/10.1053/j.semtcvs.2016.04.013.
Повний текст джерелаElOjeimy, S., J. C. McKillop, A. M. El-Zawahry, D. H. Holman, X. Liu, D. A. Schwartz, T. A. Day, J.-Y. Dong, and J. S. Norris. "FasL gene therapy: a new therapeutic modality for head and neck cancer." Cancer Gene Therapy 13, no. 8 (March 17, 2006): 739–45. http://dx.doi.org/10.1038/sj.cgt.7700951.
Повний текст джерелаHeys, S. D., D. B. Gough, L. Khan, and O. Ermin. "Nutritional pharmacology and malignant disease: A therapeutic modality in patients with cancer." British Journal of Surgery 83, no. 5 (May 1996): 608–19. http://dx.doi.org/10.1002/bjs.1800830508.
Повний текст джерелаStoiber, Stefan, Bruno L. Cadilha, Mohamed-Reda Benmebarek, Stefanie Lesch, Stefan Endres, and Sebastian Kobold. "Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy." Cells 8, no. 5 (May 17, 2019): 472. http://dx.doi.org/10.3390/cells8050472.
Повний текст джерелаGupta, Archana A., Supriya Kheur, A. Thirumal Raj, Ravindra V. Badhe, and Ramesh R. Bhonde. "Reviewing the potential use of scaffold-mediated localized chemotherapy in oncology." Forum of Clinical Oncology 11, no. 3 (December 1, 2020): 23–27. http://dx.doi.org/10.2478/fco-2019-0022.
Повний текст джерелаTruong, Cao-Sang, and So Young Yoo. "Oncolytic Vaccinia Virus in Lung Cancer Vaccines." Vaccines 10, no. 2 (February 4, 2022): 240. http://dx.doi.org/10.3390/vaccines10020240.
Повний текст джерелаDai, Chen, Ruizhi Hu, Chunmei Wang, Zhuang Liu, Shengjian Zhang, Luodan Yu, Yu Chen, and Bo Zhang. "Defect engineering of 2D BiOCl nanosheets for photonic tumor ablation." Nanoscale Horizons 5, no. 5 (2020): 857–68. http://dx.doi.org/10.1039/c9nh00707e.
Повний текст джерелаZhang, Wei, Yanli Lu, Yang Zang, Jinhui Han, Qingyun Xiong, and Jinping Xiong. "Photodynamic Therapy and Multi-Modality Imaging of Up-Conversion Nanomaterial Doped with AuNPs." International Journal of Molecular Sciences 23, no. 3 (January 22, 2022): 1227. http://dx.doi.org/10.3390/ijms23031227.
Повний текст джерелаLiu, Wei, Binbin Yang, Lu Yang, Jasmine Kaur, Calvin Jessop, Rushdi Fadhil, David Good, et al. "Therapeutic Effects of Ten Commonly Used Chinese Herbs and Their Bioactive Compounds on Cancers." Evidence-Based Complementary and Alternative Medicine 2019 (September 15, 2019): 1–10. http://dx.doi.org/10.1155/2019/6057837.
Повний текст джерелаFatima, Syeda Warisul, Khalid Imtiyaz, Mohammad M. Alam Rizvi, and Sunil K. Khare. "Microbial transglutaminase nanoflowers as an alternative nanomedicine for breast cancer theranostics." RSC Advances 11, no. 55 (2021): 34613–30. http://dx.doi.org/10.1039/d1ra04513j.
Повний текст джерелаKhan, Maliha, Anum Wasim, Aibek E. Mirrakhimov, Blaithin A. McMahon, Daniel P. Judge, Linda C. Chu, Ashtami Banavali, and Amer M. Zeidan. "Case Report of a Patient with Left Ventricular Assistance Device Undergoing Chemotherapy for a New Diagnosis of Lung Cancer." Case Reports in Oncological Medicine 2015 (2015): 1–3. http://dx.doi.org/10.1155/2015/163727.
Повний текст джерелаYamamoto, Masato, and David T. Curiel. "Cancer Gene Therapy." Technology in Cancer Research & Treatment 4, no. 4 (August 2005): 315–30. http://dx.doi.org/10.1177/153303460500400402.
Повний текст джерелаDai, Xiaofeng, Erik W. Thompson, and Kostya (Ken) Ostrikov. "Receptor-Mediated Redox Imbalance: An Emerging Clinical Avenue against Aggressive Cancers." Biomolecules 12, no. 12 (December 15, 2022): 1880. http://dx.doi.org/10.3390/biom12121880.
Повний текст джерелаYu, Qianqian, Jing Sun, Xufeng Zhu, Lin Qiu, Mengmeng Xu, Sirun Liu, Jianming Ouyang, and Jie Liu. "Mesoporous titanium dioxide nanocarrier with magnetic-targeting and high loading efficiency for dual-modal imaging and photodynamic therapy." Journal of Materials Chemistry B 5, no. 30 (2017): 6081–96. http://dx.doi.org/10.1039/c7tb01035d.
Повний текст джерелаMoll, Ute M., and Alex Zaika. "Disrupting the p53-mdm2 interaction as a potential therapeutic modality." Drug Resistance Updates 3, no. 4 (August 2000): 217–21. http://dx.doi.org/10.1054/drup.2000.0160.
Повний текст джерелаJuarranz, Ángeles, Yolanda Gilaberte, and Salvador González. "Photodynamic Therapy (PDT) in Oncology." Cancers 12, no. 11 (November 12, 2020): 3341. http://dx.doi.org/10.3390/cancers12113341.
Повний текст джерелаGuikema, Jeroen E., Martine Amiot, and Eric Eldering. "Exploiting the pro-apoptotic function of NOXA as a therapeutic modality in cancer." Expert Opinion on Therapeutic Targets 21, no. 8 (July 18, 2017): 767–79. http://dx.doi.org/10.1080/14728222.2017.1349754.
Повний текст джерелаYoshii, T., S. Tamai, O. Motohashi, K. Yonemitsu, A. Kiyohashi, S. Takagi, N. Nakayama, and Y. Murata. "Evaluation of significance of endoscopic mucosal resection (EMR) in early esophageal cancer." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 4088. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.4088.
Повний текст джерелаSekido, Yoshitaka. "Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma." Cancers 10, no. 4 (March 22, 2018): 90. http://dx.doi.org/10.3390/cancers10040090.
Повний текст джерелаTeramae, Fumio, Tomohiro Makino, Shintaro Sengoku, Yeongjoo Lim, Takashi Natori, and Kota Kodama. "Research on Pharmaceutical Product Life Cycle Patterns for Sustainable Growth." Sustainability 12, no. 21 (October 27, 2020): 8938. http://dx.doi.org/10.3390/su12218938.
Повний текст джерелаEnomoto, Keisuke, Xuguang Zhu, Sunmi Park, Li Zhao, Yuelin J. Zhu, Mark C. Willingham, Jun Qi, John A. Copland, Paul Meltzer, and Sheue-yann Cheng. "Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer." Journal of Clinical Endocrinology & Metabolism 102, no. 7 (March 28, 2017): 2268–80. http://dx.doi.org/10.1210/jc.2016-3771.
Повний текст джерелаDavis, Mark E., Zhuo Chen, and Dong M. Shin. "Nanoparticle therapeutics: an emerging treatment modality for cancer." Nature Reviews Drug Discovery 7, no. 9 (September 2008): 771–82. http://dx.doi.org/10.1038/nrd2614.
Повний текст джерелаSrinivas, Sandy. "Management of Metastatic Castration-Resistant Prostate Cancer." Journal of the National Comprehensive Cancer Network 19, no. 5.5 (May 2021): 614–16. http://dx.doi.org/10.6004/jnccn.2021.5003.
Повний текст джерелаHasegawa, Bruce H., Kenneth H. Wong, Koji Iwata, William C. Barber, Andrew B. Hwang, Anne E. Sakdinawat, Mohan Ramaswamy, David C. Price, and Randall A. Hawkins. "Dual-Modality Imaging of Cancer with SPECT/CT." Technology in Cancer Research & Treatment 1, no. 6 (December 2002): 449–58. http://dx.doi.org/10.1177/153303460200100605.
Повний текст джерелаLittle, Richard F., and Kieron Dunleavy. "Update on the treatment of HIV-associated hematologic malignancies." Hematology 2013, no. 1 (December 6, 2013): 382–88. http://dx.doi.org/10.1182/asheducation-2013.1.382.
Повний текст джерелаAtwa, Sara M., Margarete Odenthal, and Hend M. El Tayebi. "Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma." Cancers 13, no. 17 (August 27, 2021): 4343. http://dx.doi.org/10.3390/cancers13174343.
Повний текст джерелаBrizel, David. "Management of Human Papillomavirus–Induced Oropharynx Cancer." American Society of Clinical Oncology Educational Book, no. 32 (June 2012): 368–71. http://dx.doi.org/10.14694/edbook_am.2012.32.57.
Повний текст джерелаMurthy, Vedang, Sayan Kundu, Tanweer Shahid, Ashwini Budrukkar, Tejpal Gupta, Sarbani Ghosh Laskar, and Jaiprakash Agarwal. "Postoperative Radiotherapy in Head and Neck Cancer." An International Journal of Otorhinolaryngology Clinics 2, no. 1 (2010): 43–51. http://dx.doi.org/10.5005/jp-journals-10003-1016.
Повний текст джерелаDuda, Dan G., Rakesh K. Jain, and Christopher G. Willett. "Antiangiogenics: The Potential Role of Integrating This Novel Treatment Modality With Chemoradiation for Solid Cancers." Journal of Clinical Oncology 25, no. 26 (September 10, 2007): 4033–42. http://dx.doi.org/10.1200/jco.2007.11.3985.
Повний текст джерелаTormoen, Garth W., Marka R. Crittenden, and Michael J. Gough. "The TAM family as a therapeutic target in combination with radiation therapy." Emerging Topics in Life Sciences 1, no. 5 (December 12, 2017): 493–500. http://dx.doi.org/10.1042/etls20170066.
Повний текст джерелаHe, Xinjia, Qiaqia He, Lihua Wang, and Xiaofei He. "New Researches about Combinatorial Therapeutic Regimen on Cancer Treatment." Current Cancer Therapy Reviews 16, no. 2 (June 9, 2020): 97–109. http://dx.doi.org/10.2174/1573394715666190906125014.
Повний текст джерелаCha, Edward, and Lawrence Fong. "Immunotherapy for Prostate Cancer: Biology and Therapeutic Approaches." Journal of Clinical Oncology 29, no. 27 (September 20, 2011): 3677–85. http://dx.doi.org/10.1200/jco.2010.34.5025.
Повний текст джерелаHuang, Gan, and Shu-Ting Pan. "ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer." Oxidative Medicine and Cellular Longevity 2020 (July 22, 2020): 1–30. http://dx.doi.org/10.1155/2020/5047987.
Повний текст джерелаZhou, Gang, and Hyam Levitsky. "Towards Curative Cancer Immunotherapy: Overcoming Posttherapy Tumor Escape." Clinical and Developmental Immunology 2012 (2012): 1–12. http://dx.doi.org/10.1155/2012/124187.
Повний текст джерелаBhavar, Prashant Kashinath, Uday Kumar Surampudi, Partha Pratim Sarma, Satish Katike, and Adilakshmi Gandham. "Abstract A037: PROTACs as emergent treatment modality of metastatic prostate cancer. [R." Cancer Research 83, no. 2_Supplement_2 (January 15, 2023): A037. http://dx.doi.org/10.1158/1538-7445.metastasis22-a037.
Повний текст джерела